Q4 2024. Management View. CEO Mark Tarr emphasized strong financial performance in Q4 2024, with revenue increasing ...
Barclays raised the firm’s price target on Encompass Health (EHC) to $118 from $116 and keeps an Overweight rating on the shares post the Q4 ...
Trust Point Inc. decreased its holdings in Elevance Health, Inc. (NYSE:ELV – Free Report) by 4.4% in the fourth quarter, ...
Verily, Alphabet Inc.'s health technology subsidiary, announced Thursday it will sell its stop-loss insurance business, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback